Soumit Roy Analyst PerformanceManaging Director, Healthcare at JonesTradingSoumit Roy is a stock analyst at JonesTrading focused in the medical sector, covering 27 publicly traded companies. Over the past year, Soumit Roy has issued 9 stock ratings, including strong buy, buy, and hold recommendations. While full access to Soumit Roy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Soumit Roy's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings35 Last 5 YearsBuy Recommendations82.86% 29 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution35RatingsDistribution of strong buy, buy, hold, and sell ratings by Soumit Roy.RatingPercentageCount Strong Buy2.9%1 ratings Buy80.0%28 ratings Hold17.1%6 ratings Sell0.0%0 ratingsOut of 35 total stock ratings issued by Soumit Roy at JonesTrading, the majority (80.0%) have been Buy recommendations, followed by 17.1% Hold and 2.9% Strong Buy.Best & Worst CallsBest Call0000.0%ELVNMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BOLTDec 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ92.6% of companies on NASDAQ25 companiesNYSE3.7% of companies on NYSE1 companyTSE3.7% of companies on TSE1 companySoumit Roy, an analyst at JonesTrading, currently covers 27 companies listed on NASDAQ, NYSE and TSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical26 companies96.3%Manufacturing1 company3.7%Soumit Roy of JonesTrading specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE12 companies44.4%MED - DRUGS8 companies29.6%PHARMACEUTICAL PREPARATIONS4 companies14.8%MEDICAL INFO SYS1 company3.7%BIOTECHNOLOGY1 company3.7%SURGICAL & MEDICAL INSTRUMENTS1 company3.7% About Soumit RoySoumit Roy, PhD covers Biotechnology companies within the Healthcare sector. Soumit’s focus is on disruptive technology with specialization in oncology, notably T cell therapy, targeted medicines, and next generation immuno-oncology. Before joining JonesTrading, Dr. Roy was a Senior Research Associate at SunTrust Robinson Humphrey, covering small- and mid-cap biotechnology companies. He was a post-doctoral fellow in the Clinical Immunology Department at the Icahn School of Medicine at Mount Sinai, New York. He earned his PhD from the Albert Einstein College of Medicine, New York. He holds Master’s degrees in Developmental Biology and Biochemistry, and has published in the highest rated scientific journals.Follow on LinkedIn Soumit Roy's Ratings History at JonesTrading Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEDITEditas Medicine3/10/2026Upgrade$2.61$8.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals3/6/2026Downgrade$21.20$21.50Hold$0.0000.00% ROICNTXContext Therapeutics12/22/2025Initiated Coverage$1.27$7.00Buy$0.0000.00% ROIWHWKWhitehawk Therapeutics12/22/2025Initiated Coverage$2.46$7.00Buy$0.0000.00% ROIEVAXEvaxion A/S10/30/2025Initiated Coverage$5.75$10.00Buy$0.0000.00% ROIAVXLAnavex Life Sciences10/24/2025Downgrade$8.74Hold$0.0000.00% ROICGONCG Oncology9/8/2025Initiated Coverage$34.01$50.00Buy$0.0000.00% ROITARAProtara Therapeutics5/22/2025Upgrade$3.27$21.00Strong-Buy$0.0000.00% ROIAVBPArriVent BioPharma5/20/2025Initiated Coverage$19.99$40.00Buy$0.0000.00% ROIELVNEnliven Therapeutics5/16/2025Lower Price Target$16.86$27.00Buy$00.0000.00% ROIACRVAcrivon Therapeutics5/16/2025Reiterated Rating$1.15Hold$0.0000.00% ROIONCYOncolytics Biotech5/16/2025Reiterated Rating$0.47Hold$0.0000.00% ROIMURAMural Oncology3/25/2025Reiterated Rating$3.83Hold$0.0000.00% ROICRVOCervoMed3/13/2025Upgrade$5.92$15.00Buy$0.0000.00% ROINUVBNuvation Bio3/12/2025Initiated Coverage$2.31$10.00Buy$0.0000.00% ROIBEAMBeam Therapeutics3/10/2025Upgrade$26.80$34.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
